Silverlon®
www.silverlon.com



This document is available in PDF format
The Medcomp® MAg+IC™ Patch


Silver has long been known as one of the most clinically effective compounds in treating infection and promoting wound healing. Medcomp® now offers the MAg+IC™ Patch, a proprietary design of silver, whose ionic activity provides antimicrobial protection equal to the common antibiotic preparations. The benefits of the dressing include:

• Biocompatible and inorganic silver compound
• Compatible with all catheter thermoplastics and elastomers
• Will not compromise integrity of catheter materials
• No microbial resistance
 
Quick Silverlon® Links :
Ionic Silver Release Rates (bar graph) Proven To Be Hypoallergenic
Antimicrobial Dynamic Test of Surfaces - ASTM E2149 (line graph) Summary of FDA 510 (K) Clearances:
  The Safest Delivery of Pure Ionic Silver
No Metal Deposition Into the Wound With Advanced Application Technology
 
Silverlon® Ionic Silver Release Rates:

MIC
“P.” aeuroginosa		 Sustained
Delivery of
Silver Ions
=
Extended
Antimicrobial
Activity
  Time    
  blue Silverlon® Pad Dressingred Silverlon® Wound Contact Dressing  

Ionic silver release in tryptic soy broth at 37° from Silverlon® 4”x4” Wound Contact dressing.
Ionic silver release in tryptic soy broth at 37° from Silverlon® 4”x4” Wound and Burn Pad dressing. Measured by Atomic Absorption spectroscopy, test performed September 2001, data on file.
 
Silverlon® Antimicrobial Dynamic Test of Surfaces - ASTM E2149:

Rapid
Onset of
Antimicrobial
Activity
  Time  
  -- Staphylococcus aureus MRSA ATCC 33591
-- Pseudomonas aeruginosa ATCC 9027 		 

The antimicrobial activity of the Silverlon® 4”x4” Wound Contact Dressing was evaluated by the Antimicrobial Activity Dynamic Test of Surfaces, ASTM 1249 for 10.6 CFU/ml of Pseudomonas aeuroginosa ATCC 9027 and Staphylococcus aureaus (MRSA) ATCC 33591. Study conducted by the independent lab, NAMSA, Lab No. 02G 00949 00, September 2001.
 
Proven To Be Hypoallergenic

Silverlon® was tested by the independent lab, NAMSA, using the ISO Sensitization Study in the Guinea Pig (Maximization Method of Magnuson and Kligman, 1970) for the potential of delayed dermal contact sensitization. The results of these tests showed no dermal contact sensitization in the guinea pig. Silverlon® was also tested for Acute Intracutaneous Reactivity, Cytotoxicity.
Silverlon® Is Your Safe Choice
 
Summary of FDA 510 (K) Clearances:

K981299 August 10, 1998
Silverlon® Wound Contact Dressings are sterile, non-adherent antimicrobial barrier dressing applicable to partial thickness burns, incisions, skin grafts, donor sites, lacerations, abrasions and Stage I-IV dermal ulcers (vascular, venous pressure, and diabetic).

K984208 February 22, 1999
Silverlon® Island Wound and Wound Pad Dressings are multi-layer, sterile, non-adherent antimicrobial barrier wound dressings, applicable to wounds such as vascular access and peripheral IV sites, orthopedic external pin sites, wound drain sites, surgical wounds (donor and graft sites, incisions), and partial to full thickness wounds.

K984210 September 22, 1999
Silverlon® Wound Packing Strips are sterile, non-adherent antimicrobial wound packing to encourage draining by wicking fluids from a body cavity, infected area, or abscess. May also be used for control of local wound bleeding and nasal hemorrhage.

K984205 February 22, 1999
Silverlon® Adhesive Strips are absorbent composite antimicrobial barrier Adhesive Strips, for local management of superficial wounds, minor burns, and abrasions and lacerations. They are also for wounds such as vascular access of peripheral IV sites, orthopedic external pin sites, wound drain sites, and surgical incisions.
PNW294 Rev. B 3/04